Literature DB >> 12700664

p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB.

Shuling Zhang1, Xiaolan Qian, Chanelle Redman, Valeri Bliskovski, Edward S Ramsay, Douglas R Lowy, Beverly A Mock.   

Abstract

BALB/c mice are susceptible to the development of pristane-induced plasma cell tumors, and have a rare allelic variant in the coding region of the p16(INK4a) (p16) tumor suppressor gene that produces a protein with impaired activity. We have now found that the BALB/c p16 promoter has an allelic variant that may also compromise p16 activity. Following pristane treatment, BALB/c p16 mRNA levels in B cells were lower than that in DBA/2 or C.D2-Pctr1, a resistant BALB/c congenic strain that harbors DBA/2 chromatin surrounding the p16 locus. Four sequence variants were found between BALB/c and DBA/2 in the p16 promoter region. In reporter assays, the DBA promoter was at least four times more active in driving luciferase expression than the BALB/c promoter. Most of the difference in activity was localized to a single nucleotide deletion in BALB/c. This deletion created a consensus binding site for RREB, a ras-responsive transcriptional element with zinc-finger binding motifs. Transient transfections with RREB confirmed that the p16 promoter can be downregulated by RREB, in a Ras- or Mek-dependent manner, and that the BALB/c promoter is more sensitive than DBA/2 to regulation by RREB. BALB/c mice have both regulatory and coding region defects that may contribute to the impairment of p16 gene function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700664     DOI: 10.1038/sj.onc.1206257

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  42 in total

1.  The ras responsive transcription factor RREB1 is a novel candidate gene for type 2 diabetes associated end-stage kidney disease.

Authors:  Jason A Bonomo; Meijian Guan; Maggie C Y Ng; Nicholette D Palmer; Pamela J Hicks; Jacob M Keaton; Janice P Lea; Carl D Langefeld; Barry I Freedman; Donald W Bowden
Journal:  Hum Mol Genet       Date:  2014-07-15       Impact factor: 6.150

2.  The Samd9L gene: transcriptional regulation and tissue-specific expression in mouse development.

Authors:  Qiujie Jiang; Benjamin Quaynor; Alex Sun; Qiaoli Li; Hirotaka Matsui; Hiroaki Honda; Toshiya Inaba; Eli Sprecher; Jouni Uitto
Journal:  J Invest Dermatol       Date:  2011-03-17       Impact factor: 8.551

Review 3.  A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Arch Biochem Biophys       Date:  2016-04-27       Impact factor: 4.013

4.  CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia.

Authors:  Masayuki Iwasaki; Michaela Liedtke; Andrew J Gentles; Michael L Cleary
Journal:  Cell Stem Cell       Date:  2015-09-18       Impact factor: 24.633

5.  Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation.

Authors:  Tsuyoshi Akagi; Ken Sasai; Hidesaburo Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

6.  IL-6 and MYC collaborate in plasma cell tumor formation in mice.

Authors:  Sebastian Rutsch; Vishala T Neppalli; Dong-Mi Shin; Wendy DuBois; Herbert C Morse; Hartmut Goldschmidt; Siegfried Janz
Journal:  Blood       Date:  2009-12-17       Impact factor: 22.113

7.  The transcription factor MZF1 differentially regulates murine Mtor promoter variants linked to tumor susceptibility.

Authors:  Shuling Zhang; Wei Shi; Edward S Ramsay; Valery Bliskovsky; Adrian Max Eiden; Daniel Connors; Matthew Steinsaltz; Wendy DuBois; Beverly A Mock
Journal:  J Biol Chem       Date:  2019-09-23       Impact factor: 5.157

8.  Hindsight/RREB-1 functions in both the specification and differentiation of stem cells in the adult midgut of Drosophila.

Authors:  Brittany L Baechler; Cameron McKnight; Porsha C Pruchnicki; Nicole A Biro; Bruce H Reed
Journal:  Biol Open       Date:  2015-12-10       Impact factor: 2.422

9.  The human promyelocytic leukemia protein is a tumor suppressor for murine skin carcinogenesis.

Authors:  Victoria M Virador; Rafael E Flores-Obando; Adam Berry; Rinal Patel; Julia Zakhari; Yu-Chien Lo; Kathryn Strain; Joanna Anders; Christophe Cataisson; Laura A Hansen; Stuart H Yuspa
Journal:  Mol Carcinog       Date:  2009-07       Impact factor: 4.784

10.  Evolutionary and transcriptional analysis of karyopherin beta superfamily proteins.

Authors:  Yu Quan; Zhi-Liang Ji; Xiao Wang; Alan M Tartakoff; Tao Tao
Journal:  Mol Cell Proteomics       Date:  2008-03-18       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.